Showing 13,561 - 13,580 results of 226,904 for search '(( a ((teer decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.71s Refine Results
  1. 13561

    Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution by Massimiliano Gaetani (241969)

    Published 2019
    “…Compared to standard approaches where curves are fitted to protein solubility data acquired at different temperatures and drug concentrations, Proteome Integral Solubility Alteration (PISA) assay increases the analysis throughput by 1 to 2 orders of magnitude for an unlimited number of factor variation points in such a scheme. The consumption of the compound and biological material decreases in PISA by the same factor. …”
  2. 13562

    Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution by Massimiliano Gaetani (241969)

    Published 2019
    “…Compared to standard approaches where curves are fitted to protein solubility data acquired at different temperatures and drug concentrations, Proteome Integral Solubility Alteration (PISA) assay increases the analysis throughput by 1 to 2 orders of magnitude for an unlimited number of factor variation points in such a scheme. The consumption of the compound and biological material decreases in PISA by the same factor. …”
  3. 13563

    Hydrogen Adsorption on Small Zeolite-Supported Rhodium Clusters. A Density Functional Study by Velina K. Markova (1688752)

    Published 2015
    “…Using a periodic density functional approach, we modeled the dissociative adsorption of hydrogen on small Rh clusters, supported inside the cavity of a faujasite-type zeolite. …”
  4. 13564
  5. 13565

    Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution by Massimiliano Gaetani (241969)

    Published 2019
    “…Compared to standard approaches where curves are fitted to protein solubility data acquired at different temperatures and drug concentrations, Proteome Integral Solubility Alteration (PISA) assay increases the analysis throughput by 1 to 2 orders of magnitude for an unlimited number of factor variation points in such a scheme. The consumption of the compound and biological material decreases in PISA by the same factor. …”
  6. 13566
  7. 13567

    Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution by Massimiliano Gaetani (241969)

    Published 2019
    “…Compared to standard approaches where curves are fitted to protein solubility data acquired at different temperatures and drug concentrations, Proteome Integral Solubility Alteration (PISA) assay increases the analysis throughput by 1 to 2 orders of magnitude for an unlimited number of factor variation points in such a scheme. The consumption of the compound and biological material decreases in PISA by the same factor. …”
  8. 13568

    Dose-dependent suppression mediated by PCE and QRNA fractions of TNP Ts Sup. by Krzysztof Bryniarski (731989)

    Published 2015
    “…<p><u><b>a</b></u>. Three-fold decreasing doses of TNP Ts Sup-derived PCE regressively suppresses adoptive CS responses down to a dose of 15μg per eventual recipient (Groups B and C). …”
  9. 13569
  10. 13570
  11. 13571

    Data_Sheet_1_Efavirenz restored NMDA receptor dysfunction and inhibited epileptic seizures in GluN2A/Grin2a mutant mice.PDF by Teng Zhao (1486717)

    Published 2023
    “…</p>Results<p>Mutant mice showed no significant change in the mRNA or protein expressions of NMDAR compared with wild type (WT) mice. Mice with GluN2A/GRIN2A-V685G mutation exhibited shorter latency to seizure, increased frequency of seizure-like events, decreased peak current and current area of NMDAR excitatory postsynaptic current, and decreased event frequency of micro-inhibitory postsynaptic current, compared to WT mice. …”
  12. 13572
  13. 13573

    NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer by Michelle J. Schmahl (5523305)

    Published 2018
    “…The goal of the research reported here was to determine if it was possible to identify metabolic biomarkers for detection of pre-cancerous pancreatic intraepithelial neoplasia (PanIN) that precede pancreatic adenocarcinoma. The transgenic Ptf1a-Cre; LSL-KrasG12D mouse strain was used as a model of pancreatic cancer progression. …”
  14. 13574

    Proposed model of PsrA regulation of PQS production in <i>P</i>. <i>aeruginosa</i>. by Greg Wells (4672462)

    Published 2017
    “…This apparently causes a shortage of the octanoyl-CoA needed for PQS synthesis and therefore PQS production greatly decreases.…”
  15. 13575
  16. 13576
  17. 13577
  18. 13578

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”
  19. 13579

    Effects of clinical and environmental factors on bronchoalveolar antibody responses to <i>Pneumocystis jirovecii</i>: A prospective cohort study of HIV+ patients by Robert J. Blount (292240)

    Published 2017
    “…Prior PCP was associated with increased BALF IgA responses to Msg and current PCP was associated with decreased IgA responses. …”
  20. 13580

    Densitometry scan of X-ray film from normal-phase TLC of incorporation of [1-<sup>14</sup>C] acetate into lipid fraction from <i>S</i>. <i>aureus</i> following PYRC treatment. by Erica C. Larson (1344687)

    Published 2020
    “…Incorporation of radiolabeled [1-<sup>14</sup>C] acetate was decreased uniformly across the radiolabeled components of the extract in a dose-related fashion.…”